Controversy over anti-psychotic drugs subsided

Published: 2002-09-16 06:59:00
Updated: 2002-09-16 06:59:00
Jassen Korea and Lilly Korea have recently agreed that they will no longer argue over the indications and effects of their anti-psychotic drugs, Risperdal (risperidone) and Zyprexa (olanzapine).

The tentative decision of both firms to terminate the recent controversy of their anti-psychotic dr...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.